Clinical Edge Journal Scan

Beyond baseline, DBT no better than mammography for dense breasts


 

Key clinical point: In women with extremely dense breasts, digital breast tomosynthesis (DBT) does not outperform digital mammography (DM) after the initial exam.

Major finding: For baseline screening in women aged 50-59 years, recall rates per 1,000 exams dropped from 241 with DM to 204 with DBT. Cancer detection rates per 1,000 exams in this age group increased from 5.9 with DM to 8.8 with DBT. On follow-up exams, recall and cancer detection rates varied by patients’ age and breast density.

Study details: Review of 1,584,079 screenings in women aged 40-79 years.

Disclosures: The research was funded by the National Cancer Institute and the Patient-Centered Outcomes Research Institute through the Breast Cancer Surveillance Consortium. The study lead reported grants from GE Healthcare.

Source: Lowry K et al. JAMA Netw Open. 2020 Jul 1;3(7):e2011792 .

Recommended Reading

Divergent findings with paclitaxel and nab-paclitaxel in TNBC
Breast Cancer ICYMI
Cancer disparities: One of the most pressing public health issues
Breast Cancer ICYMI
The scope of under- and overtreatment in older adults with cancer
Breast Cancer ICYMI
An oncologist’s view on screening mammography
Breast Cancer ICYMI
Breast cancer screening complexities
Breast Cancer ICYMI
Radiotherapy planning scans reveal breast cancer patients’ CVD risk
Breast Cancer ICYMI
Restarting breast cancer screening after disruption not so simple
Breast Cancer ICYMI
How ObGyns can best work with radiologists to optimize screening for patients with dense breasts
Breast Cancer ICYMI
AI algorithm on par with radiologists as mammogram reader
Breast Cancer ICYMI
Study supports multigene panel testing for all breast cancer patients with second primary cancers
Breast Cancer ICYMI